Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedle vs Subcutaneous Adalimumab in Healthy Volunteers
NCT03607903Phase 2Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Jul 2018
- Primary completion
- Oct 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of adalimumab in juvenile idiopathic arthritis (JIA), sponsored by Centre for Human Drug Research. Started Jul 2018; status: completed.
02
Drugs
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NCT03607903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03607903.